Policy

Policy articles provide in-depth analysis of social and public policy, examining their wide-ranging impacts on economics, social life, public health, individual liberty, evidence-based decision-making, and institutional accountability.

We cover critical areas such as healthcare and vaccination policies, pandemic responses and WHO, economic subsidies, national security strategies, withdrawals from international bodies, and pathways to reform that restore freedom, truth, and human dignity over centralized control.

All articles from Brownstone Institute are translated into multiple languages to support global access, foster international dialogue on governance and reform, and empower readers worldwide to challenge flawed interventions.

Correcting the New York Times ACIP Reporting on Vaccine Injury

Correcting the New York Times ACIP Reporting on Vaccine Injury

Seeing Sunday’s New York Times headline titled “Confidential Report Calls for Sweeping Changes to Track Covid Vaccine Harms,” a question flashed in the minds of even the defenders of legacy vaccine policy – is the NY Times about to dismiss the Covid vaccine-injured?

Correcting the New York Times ACIP Reporting on Vaccine Injury Continue Reading

FDA Leadership’s “Blind Spots” Leads to a Surge in Medical Device and Drug Recalls

FDA Leadership’s “Blind Spots” Lead to a Surge in Medical Device and Drug Recalls

The FDA possesses the legal authority, institutional framework, and technical expertise necessary to solve this problem. What is missing is leadership’s willingness to demand the standards that once defined American drug regulation and legacy records of a low number of recalls.

FDA Leadership’s “Blind Spots” Lead to a Surge in Medical Device and Drug Recalls Continue Reading